How does Vivitrol work in the brain?

Vivitrol works in the brain by blocking opioid receptors involved in reward signaling, reinforcement, and the pleasurable effects associated with opioid and alcohol use. The medication contains extended-release naltrexone, an opioid receptor antagonist that attaches to opioid receptors without activating them. By occupying these receptors, Vivitrol reduces the ability of opioids to produce euphoric effects and may alter reward-related responses associated with alcohol use.

Opioid receptors play a major role in the brain’s reward circuitry and are involved in dopamine release associated with reinforcement and compulsive substance-seeking behavior. When opioids activate these receptors, they can produce pain relief, sedation, euphoria, and strong reinforcement signals. Vivitrol blocks receptor activation, reducing the ability of opioids to trigger these reward pathways.

The medication also affects addiction-related neurological pathways involved in craving intensity and relapse vulnerability. Although Vivitrol does not directly eliminate cravings in all individuals, opioid receptor blockade may reduce reinforcing effects that contribute to compulsive substance-seeking behavior over time. In alcohol use disorder, changes in reward signaling may contribute to reduced drinking reinforcement in some individuals.

Because Vivitrol blocks opioid receptors, individuals must generally complete opioid detoxification before starting treatment. If opioids are still present in the body, naltrexone can precipitate severe withdrawal symptoms by abruptly displacing opioids from receptors. This requirement is especially important in opioid use disorder treatment.

Vivitrol is generally viewed as a long-acting medication that targets addiction-related reward pathways through opioid receptor blockade rather than opioid receptor activation. Its effects differ substantially from medications such as methadone or buprenorphine, which activate opioid receptors to varying degrees. The medication is commonly used within medication-assisted treatment for opioid and alcohol use disorders.